Skip to main content

Decision adopted at the Extraordinary General Meeting of Shareholders

The following decision was adopted at the Extraordinary General Meeting of Shareholders of LITGRID AB (legal entity code 302564383, registered office address at Karlo Gustavo Emilio Manerheimo st. 8, LT-05131, Vilnius) (the “Company”) which was held on13-03-2026: 1. Regarding the approval of the Decision of 17 February 2026 of the Board of LITGRID AB to conclude agreements on the provision of humanitarian aid 1.1. To approve the Decision of 17 February 2026 of the Board of LITGRID to conclude humanitarian aid provision agreements with entities operating in Ukraine that meet the requirements of the Law on Development Cooperation and Humanitarian Aid of the Republic of Lithuania, and to approve the following essential terms and conditions of the humanitarian aid agreement: 1.1.1. Subject matter of the agreements – humanitarian aid to the...

Continue reading

Junshi Biosciences Announces 2025 Full Year Financial Results and Provides Corporate Updates

SHANGHAI, March 13, 2026 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial results for the full year of 2025 and provided corporate updates. FINANCIAL HIGHLIGHTSTotal revenue of Junshi Biosciences was approximately RMB2,498 million in 2025, representing an increase of approximately 28% compared to 2024, which was mainly due to the increase in revenue from sales of pharmaceutical products, in particular the domestic sales revenue of the company’s core product, toripalimab, was approximately RMB2,068 million, representing an increase of approximately 38% compared to 2024. Total research and development (“R&D”) expenses...

Continue reading

NewtekOne, Inc. Declares Dividends on Common Stock and Series B Preferred Shares

BOCA RATON, Fla., March 13, 2026 (GLOBE NEWSWIRE) — NewtekOne, Inc. (“the Company”) (NASDAQ: NEWT) announced that its Board of Directors declared a quarterly cash dividend of $0.19 per share on the Company’s outstanding common stock. The dividend is payable on April 1, 2026, to shareholders of record as of March 24, 2026. The Company’s Board of Directors also declared a dividend on the Company’s outstanding 8.500% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series B (the “Preferred Shares”) (NASDAQ: NEWTP) in the amount of $21.25 per Preferred Share, or $0.53125 per depositary share, which is equivalent to 1/40th of the dividend on the Preferred Shares, payable on April 1, 2026 to holders of record as of March 24, 2026. About NewtekOne, Inc. NewtekOne®, Your Business Solutions Company®, is a financial holding company,...

Continue reading

Lianhe Sowell International Group Ltd. Announces Non-Binding MOU with World Mobile, A Global Decentralized Communications Network Operator

SHENZHEN, CHINA, March 13, 2026 (GLOBE NEWSWIRE) — Lianhe Sowell International Group Ltd (Nasdaq: LHSW) (the “Company”), a provider of industrial machine vision products and solutions in China, today announced that it has signed a non-binding Memorandum of Understanding (MOU) for strategic cooperation with World Mobile Group Ltd, a global decentralized communications network operator. The MOU discussions were initiated and facilitated by OOKC Investment Holdings Group (“OOKC”), a global digital asset investment institution. OOKC will participate in the collaboration as a strategic facilitator and ecosystem architect, supporting the advancement of the potential collaboration. Under the cooperation framework of the MOU, the collaboration brings complementary expertise across technology, infrastructure, and capital markets together...

Continue reading

TX Rail Products Provides Financing Update

Company and Investor Mutually Agree to Terminate Previously Announced Strategic Private Placement ASHLAND, Ky., March 13, 2026 (GLOBE NEWSWIRE) — TX Rail Products, Inc, (“we, “ ”our,” ”us,” “TX Rail” or “Company”) (OTC Markets PINK: TXRP), a supplier of rail and rail products to the U.S. coal mining industry, short line railroads and tunneling contractors, today announced that previously disclosed strategic private placement financing has been terminated and will not proceed. As previously announced, on January 5, 2026, and as updated on January 16, 2026, we entered into a securities purchase agreement with an institutional accredited investor for the sale of 6,000,000 shares of our common stock at $0.30 per share for anticipated gross proceeds to us of approximately $1.8 million, along with an option for the investor to purchase...

Continue reading

Sciens Building Solutions Acquires Ninth Florida Company

Addition of Fire Safety, Inc. further expands Sciens’ Southeast presence and adds to its growing nationwide platform SAN FRANCISCO, March 13, 2026 (GLOBE NEWSWIRE) — Sciens Building Solutions (“Sciens”) today announced it has welcomed Clearwater, Florida-based Fire Safety, Inc. (“FSI”) to its growing portfolio of companies. This latest acquisition announcement from Sciens helps them further expand their presence in the Florida market, while providing FSI and its customers with even deeper resources and expertise, as well as the ability to leverage Sciens’ growing presence across the United States. “FSI’s nearly 30 years of experience was built on reliable and expert service and that is why we felt Sciens was the right partner for us,” said Steve Bussinah, FSI’s founder and owner. “Their approach is very like-minded to ours and we’re...

Continue reading

Dynagas LNG Partners LP Reports Results for the Three and Twelve Months Ended December 31, 2025

ATHENS, Greece, March 13, 2026 (GLOBE NEWSWIRE) — Dynagas LNG Partners LP (NYSE: “DLNG”) (the “Partnership”), an owner of liquefied natural gas (“LNG”) carriers, today announced its results for the three and twelve months ended December 31, 2025. Twelve months Highlights:Net Income and Earnings per common unit (basic and diluted) of $61.6 million and $1.38, respectively; Adjusted Net Income(1) of $57.1 million and Adjusted Earnings per common unit(1) (basic and diluted) of $1.26; Adjusted EBITDA(1) of $109.2 million; and 99.3% fleet utilization(2).Quarter Highlights:Net Income and Earnings per common unit (basic and diluted) of $15.7 million and $0.38, respectively; Adjusted Net Income(1) of $14.1 million and Adjusted Earnings per common unit(1) (basic and diluted) of $0.34; Adjusted EBITDA(1) of $26.9 million; 98.8% fleet...

Continue reading

Nexentis Technologies Inc. Launches New Corporate Website, Showcasing Innovative AI-Driven Biotech Platform

Visit Nexentis at: www.nexentistech.com Neve Yarak, Israel, March 13, 2026 (GLOBE NEWSWIRE) — Nexentis Technologies Inc. (NASDAQ: NXTS), (“Nexentis” and the “Company”), a drug discovery company that is also investing in solar energy assets based on the RTB (Ready to Build) business model, is proud to announce the launch of its new corporate website at www.nexentistech.com. This digital milestone follows the company’s recent rebranding from N2OFF, Inc., and underscores its commitment to advancing mitochondrial biology for breakthroughs in precision oncology and inflammatory metabolic diseases. The newly launched website serves as a comprehensive hub for stakeholders, including investors, partners, and the scientific community, to explore Nexentis’ transformative platform. Key features include detailed insights into the...

Continue reading

Akari Therapeutics Releases CEO Corner Highlighting Strategic Progress and Path to Clinical Development Under CEO Abizer Gaslightwala

Highlights strategic progress achieved under Abizer Gaslightwala’s leadership, including advancement of AKTX-101 and expansion of Akari’s ADC pipeline  Access the Akari CEO Corner here TAMPA, Fla. and LONDON, March 13, 2026 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel immuno-oncology payloads, today released a new CEO Corner segment featuring President and Chief Executive Officer Abizer Gaslightwala reflecting on his first year leading the Company and the strategic progress achieved during that time. Over the past year under Abizer Gaslightwala’s leadership, Akari Therapeutics has sharpened its strategic focus and advanced the development of its proprietary PH1 ADC payload platform. In the latest CEO Corner, Mr. Gaslightwala highlights...

Continue reading

WISDOMTREE MULTI ASSET ISSUER PUBLIC LIMITED COMPANY (a public company incorporated with limited liability in Ireland) WISDOMTREE FTSE 100 2X DAILY SHORT SECURITIES ISIN: IE00B94QKF15

13 March 2026 LEI: 2138003QW2ZAYZODBU23 LSE Code: 2UKS WISDOMTREE MULTI ASSET ISSUER PUBLIC LIMITED COMPANY(a public company incorporated with limited liability in Ireland)WISDOMTREE FTSE 100 2X DAILY SHORT SECURITIESISIN: IE00B94QKF15PROPOSED AMENDMENT TO THE PRINCIPAL AMOUNT OF THE AFFECTED SECURITIES ADJOURNMENT OF MEETING OF THE ETP SECURITYHOLDERS THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. If you are in any doubt about what action you should take, you are recommended to consult your independent financial adviser. If you have sold or transferred all of your WisdomTree FTSE 100 2x Daily Short Securities (the “Affected Securities”) of WisdomTree Multi Asset Issuer Public Limited Company (the “Issuer”), please send this document, together with the accompanying form of proxy, at once to the purchaser or transferee...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.